Skip to main content

Showing results for Indiana Health

IU School of Medicine researchers discover gamechanger combination drug for triple negative breast cancer

A team of Indiana University School of Medicine researchers has developed a novel antibody-drug conjugate for treating triple negative breast cancer. 

IU School of Medicine  |  Feb 23, 2021

IU School of Medicine researchers identify disease-related gene changes in kidney tissue

Researchers from Indiana University have identified key genetic changes in the interstitial kidney tissue of people with diabetes, a discovery that signifies the potential for a revolutionary new genetic approach to the treatment of kidney disease.

IU School of Medicine  |  Feb 16, 2021

IU School of Medicine reaches NIH funding milestone, continues record-setting trend

INDIANAPOLIS—For the fifth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, showcasing its continued leadership in the field of medical research.

IU School of Medicine  |  Jan 27, 2021

Researchers learn to predict very preterm birth, neonatal complications in early pregnancy

Researchers are learning more about ways to predict the likelihood of newborn complications from early in pregnancy using samples provided by the Indiana University School of Medicine Building Blocks of Pregnancy Biobank.

IU School of Medicine  |  Jan 07, 2021

IU School of Medicine launches new regenerative medicine PhD program aimed at workforce development

Indiana University School of Medicine is excited to announce a new PhD program in regenerative medicine and technologies, a rapidly growing discipline which will shape the future of health care.

IU School of Medicine  |  Jan 05, 2021

IU School of Medicine researchers publish first scientific article dedicated to Tyler Trent’s donated tumors, his legacy

Researchers at Indiana University School of Medicine have published their work about a specific type of childhood cancer in the peer-reviewed, international oncology journal, Cancers. This research involves a combination therapy that significantly slows tumor growth in models, which includes a model established from cells taken from tumors donated by Tyler Trent.

IU School of Medicine  |  Dec 01, 2020

COVID-19 vaccine study underway at IU School of Medicine

Indiana University School of Medicine announced today that several Hoosier volunteers are now enrolled in the late stage clinical study of an investigational COVID-19 vaccine known as AZD1222, taking place at IU Health University Hospital. Within days of announcing IU School of Medicine as one of the study sites, more than 3,000 Hoosiers created volunteer profiles through All IN for Health, a program of the Indiana Clinical and Translational Sciences Institute (CTSI).

IU School of Medicine  |  Nov 17, 2020

An evolutionary cul-de-sac: Study suggests most humans are vulnerable to Type 2 diabetes

Scientists have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to Type 2 diabetes. A recent study from scientists at Indiana University School of Medicine, the University of Michigan and Case Western Reserve University has determined that the sequence of insulin has become entrenched at the edge of impaired production, an intrinsic vulnerability unmasked by rare mutations in the insulin gene causing diabetes in childhood

IU School of Medicine  |  Nov 02, 2020

New psychiatry residency program hopes to ease physician shortage in northwest Indiana

Indiana University School of Medicine is partnering with the Northwest Indiana GME Consortium to launch a new psychiatry residency program at its regional campus in northwest Indiana aimed at treating an underserved population in that part of the state.

Christina Griffiths  |  Oct 20, 2020

IU researchers join nationwide effort to use artificial intelligence in study of Alzheimer's disease

A new $17.8 million grant will help researchers discover novel ways to prevent and treat Alzheimer’s disease through state-of-the-art artificial intelligence (AI) methods.

Christina Griffiths  |  Oct 15, 2020